We are excited to announce that ADEXILIS Turkey launched just in time for 2020 its new digital healthcare platform www.sagligadestek.com. Patient centricity is a key element of our strategy. Providing our customers and patients in need clearly differentiated and superior …
In 2017, RBV Capital acquired an equity stake in an innovative UK-based company developing an asset for treating symptoms of multiple sclerosis. Later in 2017, the company received poor results of the clinical trial of its sole asset: the efficacy …
ADEXILIS is happy to announce that we obtained reimbursement for another life saving therapy in Czech Republic. Together with our partner we demonstrated our ability to authorities the true value of our therapy. Jiri Kubacek, General Manager Adexilis Czech Republic …